Alprostadil Completed Phase 4 Trials for Peripheral Arterial Occlusive Disease (PAOD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00596752Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV